David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, announced today that David R. King has been appointed as the Company’s Chairman of the Board.